TOVX

Theriva Biologics Inc

$0.24

+0.01 (+2.61%)

Analyst Overview

Target Price:

Date: 15.07.2026

$2.50

(+941.23%)

Strong Buy: 0

Buy: 0

Hold: 0

Sell: 0

Strong Sell: 0

Description:

Theriva Biologics Inc., a clinical-stage company, develops therapies to treat diseases in areas of high unmet need. The company is headquartered in Rockville, Maryland.

Exchange:

NYSE MKT

Country:

USA

Sector:

HEALTHCARE

Industry:

BIOTECHNOLOGY

Address:

9605 MEDICAL CENTER DRIVE, ROCKVILLE, MD, UNITED STATES, 20850

Fiscal year end:

December

Market capitalization:

$10.7 Million

EBITDA:

-$12.6 Million

PERatio:

0.0

EPS:

-0.58

Dividend per share:

$0.00

Dividend yield:

0.0%

Beta:

1.095

Dividends for 10 years

Income Statements for 10 years

Earnings calender

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:

$1,000

How much will you earn in 10 years:

-100%

How much will you get:

Prices dates:

30-06-2016: $15,750.00 and 30-06-2026: $0.25